Fujifilm Diosynth Biotechnologies is a manufacturing company focusing on contract process development, clinical and commercial cGMP contract manufacturing of complex recombinant proteins, vaccines, antibody derivatives, enzymes, and fusion proteins. Founded in 2011 and based in Morrisville, NC, the company has established itself as a leader in its field with a strong reputation for quality and innovation.
Under the leadership of CEO Martin Meeson, Fujifilm Diosynth Biotechnologies has grown to employ around 3,000 people and generates an annual revenue of $124,300,000. The company is known for its competitive employee salaries, averaging $81,542 per year. It competes with other prominent companies in the industry, such as Merck, Sanofi Genzyme, and Emergent BioSolutions.